Serum zinc level and coronary heart disease events in patients with type 2 diabetes

Diabetes Care

Volumn 30, Issue 3, 2007, Pages 523-528

  Soinio, Minna ^a,e   Marniemi, Jukka ^b   Laakso, Markku ^c   Pyörälä, Kalevi ^c   Lehto, Seppo ^d   Rönnemaa, Tapani ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ZINC;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; ZINC BLOOD LEVEL;

AGE OF ONSET; BODY MASS INDEX; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; FINLAND; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ZINC;

EID: 33847670592     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1682     Document Type: Article

References (35)

1. Powell S: The antioxidant properties of zinc. J Nutr 130:1447S-1454S, 2000
2. Kinlaw W, Levine A, Morley J, Silvis S, McClain C: Abnormal zinc metabolism in type II diabetes mellitus. Am J Med 75:273-277, 1983
3. Reunanen A, Knekt P, Marniemi J, Mäki J, Maatela J, Aromaa A: Serum calcium, magnesium, copper and zinc and risk of cardiovascular death. Eur J Clin Nutr 50:431-437, 1996
4. Singh R, Niaz M, Rastogi S, Bajaj S, Gaoli Z, Shoumin Z: Current zinc intake and risk of diabetes and coronary artery disease and factors associated with insulin resistance in rural and urban populations of North India. J Am Coll Nutr 17:564-570, 1998
5. Lee D-H, Folsom A, Jacobs D: Iron, zinc, and alcohol consumption and mortality from cardiovascular diseases: the Iowa Women's Health Study. Clin Nutr 81:787-791, 2005
6. Laakso M, Rönnemaa T, Pyörälä K, Kallio V, Puukka P, Penttilä I: Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic 0subjects in Finland. Diabetes Care 11:449-463, 1988
7. Rose G, Blackburn H, Gillum R, Prineas R: Cardiovascular Survey Methods. 2nd ed. Geneva, World Health Org., 1982
8. World Health Organization: Proposal for the Multinational Monitoring of Trends and Determinants in Cardiovascular Disease and Protocol (MONICA) Project. Rev 1. Geneva, World Health Org., 1983 (WHO/MNC/82.1)
9. Kostner G: Enzymatic determination of cholesterol in high-density lipoprotein fractions prepared by polyanion precipitation (Letter). Clin Chem 22:695, 1976
10. Meret S, Hankin R: Simultaneous direct estimation by atomic absorption spectrophotometry of copper and zinc in serum, urine and cerebrospinal fluid. Clin Chem 17:369-373, 1971
11. Niewohner C, Allen J, Boosalis M, Levine A, Morley J: Role of zinc supplementation in type II diabetes mellitus. Am J Med 81:63-68, 1986
12. Chausmer A: Zinc, insulin and diabetes. J Am Coll Nutr 17:109-115, 1998
13. Roussel A-M, Kerkeni A, Zouari N, Mahjoub S, Matheau J-M, Anderson R: Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. J Am Coll Nutr 22:316-321, 2003
14. Anderson R, Roussel A-M, Zouari N, Mahjoub S, Matheau J-M, Kerkeni A: Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. J Am Coll Nutr 20:212-218, 2001
15. Faure P, Benhamou P, Perard A, Halimi S, Roussel A: Lipid peroxidation in insulin dependent diabetic patients with early retina degenerative lesions: effects of an oral zinc supplementation. Eur J Clin Nutr 49:282-288, 1995
16. Zureik M, Galan P, Bertrais S, Mennen L, Czernichow S, Blacher J, Ducimetiere P, Hercberg S: Effects of long-term daily low-dose supplementation with antioxidant vitamins and minerals on structure and function of large arteries. Arterioscler Thromb Vasc Biol 24:1485-1491, 2004
17. Bettger W, O'Dell B: A critical physiological role of zinc in the structure and function of biomembranes. Life Sci 28:1425-1438, 1981
18. Bray T, Bettger W: The physiological role of zinc as an antioxidant. Free Rad Biol Med 8:281-291, 1990
19. Hennig B, Meerarani P, Toborek M, McClain C: Antioxidant-like properties of zinc in activated endothelial cells. J Am Coll Nutr 18:152-158, 1999
20. Arquilla E, Packer S, Tarmas W, Miyamoto S: The effect of zinc on insulin metabolism. Endocrinology 103:1440-1449, 1978
21. Meerarani P, Ramadass P, Toborek M, Bauer H-C, Bauer H, Hennig B: Zinc protects against apoptosis of endothelial cells induced by linoleic acid and tumor necrosis factor α. Am J Clin Nutr 71:81-87, 2000
22. Hennig B, Meerarani P, Ramadass P, Toborek M, Malecki A, Slim R, McClain CJ: Zinc nutrition and apoptosis of vascular endothelial cells: implications in atherosclerosis. Nutrition 15:744-748, 1999
23. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820, 2001
24. Laight D, Carrier M, Ánggård E: Antioxidants, diabetes and endothelial dysfunction. Cardiovasc Res 47:457-464, 2000
25. Maxwell S, Thomason H, Sandler D, Leguen C, Baxter MA, Thorpe GH, Jones AF, Barnett AH: Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 27:484-490, 1997
26. King G, Loeken M: Hyperglycemia induced oxidative stress in diabetic complications. Histochem Cell Biol 122:333-338, 2004
27. Diaz M, Frei B, Vita J, Keaney J: Antioxidants and atherosclerotic heart disease. N Engl J Med 337:408-416, 1997
28. Kaliora A, Dedoussis G, Schmidt H: Dietary antioxidants in preventing atherogenesis. Atherosclerosis 187:1-17, 2006
29. Davi G, Falco A, Patrono C: Lipid peroxidation in diabetes mellitus. Antioxid Redox Signal 7:256-268, 2005
30. Oranje W, Wolffenbuttel B: Lipid peroxidation and atherosclerosis in type II diabetes. J Lab Clin Med 134:19-32, 1999
31. Faure P, Corticelli P, Richard M, Arnaud J, Coudray C, Halimi S, Favier A, Roussel AM: Lipid peroxidation and trace element status in diabetic ketotic patients: influence of insulin therapy. Clin Chem 39:789-793, 1993
32. Anetor J, Senjobi A, Ajose O, Agbedana E: Decreased serum magnesium and zinc levels: atherogenic implications in type 2 diabetes mellitus in Nigerians. Nutr Health 16:291-300, 2002
33. Pyörälä K, Lehto S, De Bacquer D, De Sutter J, Sans S, Keil U, Wood D, De Backer G, EUROASPIRE I Group, EUROASPIRE II Group: Risk factor management in diabetic and non-diabetic patients with coronary heart disease: findings from the EUROASPIRE I and II surveys. Diabetologia 47:1257-1265, 2004
34. Colhoun H, Betteridge D, Durrington P, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH, CARDS investigators: Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364:685-696, 2004
35. Halliwell B: The antioxidant paradox. Lancet 355:1179-1180, 2000